Immunohistochemical Determination of Mtor Pathway Molecules in Ovaries and Uterus in Rat Estrous Cycle Stages
| dc.contributor.author | Ekizceli, Gulcin | |
| dc.contributor.author | Inan, Sevinc | |
| dc.contributor.author | Oktem, Gulperi | |
| dc.contributor.author | Onur, Ece | |
| dc.contributor.author | Ozbilgin, Kemal | |
| dc.date.accessioned | 2023-06-16T14:38:45Z | |
| dc.date.available | 2023-06-16T14:38:45Z | |
| dc.date.issued | 2020 | |
| dc.description.abstract | mTOR is a member of the PI3K/Akt/mTOR signaling pathway that participates in cell growth, proliferation, protein synthesis, transcription, angiogenesis, apoptosis and autophagy. mTOR and MAPK pahways are two important key signal pathways which are related to each other. We investigated the role of mTOR and other signaling molecules in rat ovaries and uteruses in stages of the estrous cycle. Young adult female rats were divided into four groups as proestrous, estrous, metestrous and diestrous according to vaginal smears. Immunohistochemical staining of mTORC1, IGF1, PI3K, pAKT1/2/3, ERK1 and pERK1/2 was performed and pAKT1/2/3 and ERK1 were also analyzed using western blotting on ovarian and uterine tissue samples. According to our results, PI3K/Akt/ mTOR and ERK/pERK showed an increase in the rat ovulation period. When all the groups were evaluated the immunoreactivities for all of the antibodies were detected in the oocytes, granulosa and theca cells, corpus luteum and stroma of ovary and lamina propria, surface and glandular epithelium of uterus with the strongest observed with anti-ERK1 antibody and then with a decreasing trend with anti-mTORC1, anti-pAkt1/2/3, anti-IGF1, anti-PI3K and anti-pERK1/2 antibodies in the proestrus and estrus stages. Differently from other parts of the ovary, highest antibody expression in the corpus luteum was observed in the metestrous stage. Moreover, the existence of pAKT1/2/3 and ERK1 proteins was confirmed with the Western blotting technique. We suggest that mTOR and mTOR-related ERK signaling molecules may participate in the rat ovulation process. | en_US |
| dc.description.sponsorship | Celal Bayar University, Scientific Research Project Committee [2011/038] | en_US |
| dc.description.sponsorship | This research was granted by Celal Bayar University, Scientific Research Project Committee. Number 2011/038. | en_US |
| dc.identifier.doi | 10.14670/HH-18-258 | |
| dc.identifier.issn | 0213-3911 | |
| dc.identifier.issn | 1699-5848 | |
| dc.identifier.uri | https://doi.org/10.14670/HH-18-258 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14365/2303 | |
| dc.language.iso | en | en_US |
| dc.publisher | F Hernandez | en_US |
| dc.relation.ispartof | Hıstology And Hıstopathology | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | ERK | en_US |
| dc.subject | Estrous cycle | en_US |
| dc.subject | IGF1 | en_US |
| dc.subject | mTORC1 | en_US |
| dc.subject | Ovulation | en_US |
| dc.subject | pAKT | en_US |
| dc.subject | Increased Activation | en_US |
| dc.subject | Follicle Activation | en_US |
| dc.subject | Mammalian Target | en_US |
| dc.subject | Pi3k/Akt Pathway | en_US |
| dc.subject | Gene-Expression | en_US |
| dc.subject | Granulosa-Cells | en_US |
| dc.subject | Growth-Factors | en_US |
| dc.subject | Pten | en_US |
| dc.subject | Tor | en_US |
| dc.subject | Folliculogenesis | en_US |
| dc.title | Immunohistochemical Determination of Mtor Pathway Molecules in Ovaries and Uterus in Rat Estrous Cycle Stages | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication | |
| gdc.author.id | Ekizceli, Gulcin/0000-0001-9513-5706 | |
| gdc.bip.impulseclass | C5 | |
| gdc.bip.influenceclass | C5 | |
| gdc.bip.popularityclass | C5 | |
| gdc.coar.access | metadata only access | |
| gdc.coar.type | text::journal::journal article | |
| gdc.description.department | İzmir Ekonomi Üniversitesi | en_US |
| gdc.description.departmenttemp | [Ekizceli, Gulcin] Istanbul Hlth & Technol Univ, Fac Med, Dept Histol & Embryol, Istanbul, Turkey; [Inan, Sevinc] Izmir Econ Univ, Sch Med, Dept Histol & Embryol, Izmir, Turkey; [Oktem, Gulperi] Ege Univ, Dept Histol & Embryol, Sch Med, Izmir, Turkey; [Onur, Ece] Manisa Celal Bayar Univ, Sch Med, Dept Med Biochem, Manisa, Turkey; [Ozbilgin, Kemal] Manisa Celal Bayar Univ, Sch Med, Dept Histol & Embryol, Manisa, Turkey | en_US |
| gdc.description.endpage | 1351 | en_US |
| gdc.description.issue | 11 | en_US |
| gdc.description.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| gdc.description.scopusquality | Q2 | |
| gdc.description.startpage | 1337 | en_US |
| gdc.description.volume | 35 | en_US |
| gdc.description.wosquality | Q2 | |
| gdc.identifier.pmid | 32940340 | |
| gdc.identifier.wos | WOS:000608634300011 | |
| gdc.index.type | WoS | |
| gdc.index.type | PubMed | |
| gdc.oaire.diamondjournal | false | |
| gdc.oaire.impulse | 0.0 | |
| gdc.oaire.influence | 2.4895952E-9 | |
| gdc.oaire.isgreen | true | |
| gdc.oaire.keywords | Ovulation | |
| gdc.oaire.keywords | Estrous cycle | |
| gdc.oaire.keywords | TOR Serine-Threonine Kinases | |
| gdc.oaire.keywords | IGF1 | |
| gdc.oaire.keywords | pAKT | |
| gdc.oaire.keywords | Ovary | |
| gdc.oaire.keywords | Uterus | |
| gdc.oaire.keywords | Estrous Cycle | |
| gdc.oaire.keywords | Mechanistic Target of Rapamycin Complex 1 | |
| gdc.oaire.keywords | Immunohistochemistry | |
| gdc.oaire.keywords | ERK | |
| gdc.oaire.keywords | Animals | |
| gdc.oaire.keywords | Female | |
| gdc.oaire.keywords | Insulin-Like Growth Factor I | |
| gdc.oaire.keywords | Phosphatidylinositol 3-Kinase | |
| gdc.oaire.keywords | Phosphorylation | |
| gdc.oaire.keywords | Rats, Wistar | |
| gdc.oaire.keywords | Extracellular Signal-Regulated MAP Kinases | |
| gdc.oaire.keywords | mTORC1 | |
| gdc.oaire.keywords | Proto-Oncogene Proteins c-akt | |
| gdc.oaire.keywords | Signal Transduction | |
| gdc.oaire.keywords | CDU::6 - Ciencias aplicadas::61 - Medicina::616 - Patología. Medicina clínica. Oncología | |
| gdc.oaire.keywords | pAkt | |
| gdc.oaire.popularity | 1.3503004E-9 | |
| gdc.oaire.publicfunded | false | |
| gdc.oaire.sciencefields | 03 medical and health sciences | |
| gdc.oaire.sciencefields | 0302 clinical medicine | |
| gdc.opencitations.count | 0 | |
| gdc.plumx.mendeley | 6 | |
| gdc.plumx.pubmedcites | 2 | |
| gdc.plumx.scopuscites | 3 | |
| gdc.virtual.author | İnan, Sevinç | |
| gdc.wos.citedcount | 2 | |
| relation.isAuthorOfPublication | 521732ce-edce-4553-9b48-dd7f41606a3a | |
| relation.isAuthorOfPublication.latestForDiscovery | 521732ce-edce-4553-9b48-dd7f41606a3a | |
| relation.isOrgUnitOfPublication | 4cbb0a74-ee1a-438b-b714-b8ef253df94b | |
| relation.isOrgUnitOfPublication | fbc53f3e-d1d3-4168-afd8-e42cd20bddd9 | |
| relation.isOrgUnitOfPublication | e9e77e3e-bc94-40a7-9b24-b807b2cd0319 | |
| relation.isOrgUnitOfPublication.latestForDiscovery | 4cbb0a74-ee1a-438b-b714-b8ef253df94b |
Files
Original bundle
1 - 1 of 1
